Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence

INTRODUCTION: Despite being frequently diagnosed, there has been very limited study of efficacious treatments for schizoaffective disorder. Paliperidone had been approved for the treatment of schizoaffective disorder, and a recently completed relapse prevention study of the use of a once-monthly inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenberg, William M., Citrome, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685865/
https://www.ncbi.nlm.nih.gov/pubmed/26662360
http://dx.doi.org/10.1007/s40120-015-0030-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685865/
https://www.ncbi.nlm.nih.gov/pubmed/26662360
http://dx.doi.org/10.1007/s40120-015-0030-4

Ejemplares similares